V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001171 | 330000644 | 1.67 | 63.2 | Curative (C) | null | 2013-06-03 | Cisplatin | 02 | Y | 330002955 | CISPLATIN |
| 330001172 | 330000644 | 1.55 | 14.1 | Curative (C) | 2014-04-30 | 2014-05-03 | Cisplatin 7 day | N | Y | 330002955 | CISPLATIN |
| 330001173 | 330000645 | 1.5 | 20.7 | Curative (C) | 2014-06-13 | 2014-07-31 | Cisplatin 7 day | 02 | null | 330002960 | CISPLATIN |
| 330001174 | 330000645 | 1.69 | 55.4 | Curative (C) | 2014-12-03 | 2015-01-06 | Cisplatin | N | Y | 330002960 | CISPLATIN |
| 330001175 | 330000645 | 1.67 | 15 | Curative (C) | 2014-07-02 | 2014-07-22 | Cisplatin | N | Y | 330002960 | CISPLATIN |
| 330001176 | 330000646 | 1.57 | 48 | Curative (C) | null | 2014-07-25 | Cisplatin | N | null | 330002965 | CISPLATIN |
| 330001178 | 330000648 | null | 0 | Neo-adjuvant (N) | 2014-03-05 | 2014-03-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330002971 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001179 | 330000648 | 1.8 | 13 | Curative (C) | 2014-03-27 | 2014-04-04 | Cisplatin | N | N | 330002971 | CISPLATIN |
| 330001180 | 330000649 | 0 | 90 | Curative (C) | 2014-03-09 | 2014-03-22 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330002979 | NOT MATCHED |
| 330001181 | 330000650 | 1.78 | 17 | Curative (C) | 2016-10-11 | 2016-11-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002981 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001182 | 330000651 | null | 80.4 | Curative (C) | 2013-05-24 | 2013-05-27 | CNS LGG 2004 03 cons vinc + carbo | N | N | 330002984 | NOT MATCHED |
| 330001183 | 330000652 | null | null | Neo-adjuvant (N) | 2017-09-28 | 2017-09-28 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330002986 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001184 | 330000652 | 1.6 | null | Palliative (P) | null | 2015-10-24 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 330002986 | NOT MATCHED |
| 330001185 | 330000652 | 1.6 | 7.7 | Curative (C) | 2016-02-15 | 2016-02-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002986 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001187 | 330000654 | 1.66 | 15.7 | Curative (C) | 2014-05-22 | 2014-05-23 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330002998 | NOT MATCHED |
| 330001188 | 330000655 | 1.6 | 165.3 | Neo-adjuvant (N) | null | 2015-02-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330002999 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001189 | 330000656 | null | 77 | Not known (9) | 2014-12-07 | 2015-01-03 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330003007 | NOT MATCHED |
| 330001190 | 330000657 | 1.68 | null | Neo-adjuvant (N) | 2017-09-01 | 2017-09-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003010 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001191 | 330000658 | null | 58.3 | Curative (C) | 2013-05-23 | 2013-06-04 | NB HRNBL-1 BUMEL MAT | Y | N | 330003012 | NOT MATCHED |
| 330001192 | 330000658 | 1.78 | 42 | Neo-adjuvant (N) | 2016-10-13 | 2016-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003012 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001193 | 330000659 | 1.8 | 59.2 | Neo-adjuvant (N) | 2015-11-12 | 2015-12-20 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003016 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001194 | 330000660 | 1.87 | 56.9 | Disease modification (D) | 2017-01-04 | 2017-02-01 | Trial Unspecified | Y | Y | 330003017 | TRIAL |
| 330001195 | 330000661 | 1.8 | 99.2 | Neo-adjuvant (N) | null | 2016-04-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003019 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001196 | 330000662 | 0 | 90 | Curative (C) | 2015-01-13 | 2015-01-16 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330003028 | NOT MATCHED |
| 330001197 | 330000663 | 1.8 | 88.7 | Curative (C) | null | 2017-01-26 | Cisplatin | N | null | 330003033 | CISPLATIN |
| 330001198 | 330000664 | 1.67 | 64 | Neo-adjuvant (N) | 2016-02-01 | 2016-03-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001199 | 330000665 | 0 | 12.4 | Curative (C) | 2017-09-25 | 2017-09-27 | CYCLOPHOSPHAMIDE + RITUXIMAB + prednisolone | 02 | N | 330003041 | NOT MATCHED |
| 330001200 | 330006420 | null | 99.1 | Curative (C) | 2015-06-09 | 2015-06-10 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330003042 | NOT MATCHED |
| 330001201 | 330000666 | null | 77.6 | Neo-adjuvant (N) | 2014-05-20 | 2014-06-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003045 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001202 | 330000666 | 1.78 | 26.4 | null | 2015-10-05 | 2015-10-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003045 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001203 | 330000666 | 1.6 | 4.3 | Palliative (P) | 2016-06-21 | 2016-07-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003045 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001204 | 330000667 | 1.6 | 66.8 | Curative (C) | 2016-03-01 | 2016-04-04 | Cisplatin | 02 | Y | 330003053 | CISPLATIN |
| 330001205 | 330006422 | 1.81 | 68.5 | Palliative (P) | 2015-04-01 | 2015-05-14 | Cisplatin | null | Y | 330003061 | CISPLATIN |
| 330001206 | 330006422 | 1.76 | 11.5 | Curative (C) | 2016-01-23 | 2016-01-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330003061 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001207 | 330000668 | 1.67 | 65 | Curative (C) | 2017-09-14 | 2017-10-12 | Cisplatin | N | Y | 330003065 | CISPLATIN |
| 330001210 | 330000670 | 0 | 80 | Curative (C) | 2016-12-07 | 2016-12-10 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330003074 | NOT MATCHED |
| 330001211 | 330000671 | 1.68 | 84 | Neo-adjuvant (N) | 2014-09-30 | 2014-10-20 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003076 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001212 | 330000672 | 1.55 | 82.6 | null | 2015-08-21 | 2015-09-13 | Cisplatin | null | Y | 330003077 | CISPLATIN |
| 330001214 | 330000674 | 1.62 | 11.2 | null | 2017-01-12 | 2017-01-18 | Cisplatin | 02 | Y | 330003079 | CISPLATIN |
| 330001215 | 330000675 | 1.62 | 62.85 | Curative (C) | 2014-03-19 | 2014-03-19 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330003080 | TRIAL |
| 330001216 | 330006424 | 0 | null | Neo-adjuvant (N) | 2013-12-02 | 2013-12-02 | Trial Unspecified | 02 | N | 330003082 | TRIAL |
| 330001217 | 330000676 | 1.72 | 82.5 | null | 2013-12-16 | 2014-01-02 | Cisplatin | null | Y | 330003083 | CISPLATIN |
| 330001218 | 330000677 | 1.65 | 62 | Neo-adjuvant (N) | null | 2014-12-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003085 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001219 | 330000678 | null | 73.8 | Curative (C) | 2013-10-13 | 2013-10-15 | STS Rhabdo RMS 2005 | 02 | N | 330003086 | NOT MATCHED |
| 330001220 | 330000678 | null | 9.1 | Curative (C) | null | 2015-11-27 | Cisplatin 7 day | N | Y | 330003086 | CISPLATIN |
| 330001221 | 330000679 | null | 65.2 | Disease modification (D) | 2017-03-25 | 2017-03-26 | OST Euramos 1 Closed Trial - Ai | Y | N | 330003101 | NOT MATCHED |
| 330001222 | 330000680 | 0 | 57 | Curative (C) | 2014-02-23 | 2014-03-01 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330003103 | NOT MATCHED |
| 330001223 | 330000681 | 1.75 | 66.45 | Curative (C) | 2016-12-17 | 2017-01-20 | Cisplatin 7 day | N | null | 330003104 | CISPLATIN |
| 330001224 | 330000682 | 0 | 86.4 | Palliative (P) | 2014-10-14 | 2014-10-28 | EW EuroEwing 2012 Arm B VDC | N | null | 330003105 | TRIAL |
| 330001225 | 330000683 | null | 57.1 | Curative (C) | 2015-11-23 | 2015-12-08 | Cisplatin 7 day | 2 | N | 330003109 | CISPLATIN |